CheckMyStock - Developed By GMS Ahimsa
CS Diagnostics Corp. (CSDX)
$0.13 0.00 (0.00%)
Financial Ratios
Book Value per Share (BVPS)
N/A
Net asset value per share of common stock
Debt-to-Equity Ratio
0.00
(Financial Modeling Prep)
Measures financial leverage and company risk
Return on Invested Capital (ROIC)
0.00%
(Financial Modeling Prep)
Efficiency of capital allocation for generating returns
Price-to-Earnings Ratio (P/E)
N/A
Shows how much investors are willing to pay per dollar of earnings
Company Information
Company Name
CS Diagnostics Corp.
Stock Ticker
CSDX
Market Cap
N/A
52 Week Range
0.036-0.55
Price
$0.13
Dividend Yield
N/A
About CS Diagnostics Corp.
CS Diagnostics Corp. engages in designing, manufacturing, and selling of wellness and medical products in Germany and internationally. The company offers MEDUSA, proprietary surface disinfectant product; and CS-Protect Hydrogel, a tissue spacer gel for use in radiation therapy. The company was formerly known as FlashZero Corp. and changed its name to CS Diagnostics Corp. in August 2023. The company was incorporated in 1996 and is based in Neuss, Germany.